Who makes Aripezil® Tab.?

Aripezil® Tab. is developed by Yuhan Corporation.

What development phase is Aripezil® Tab. in?

Aripezil® Tab. is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Aripezil® Tab.

Yuhan Corporation · FDA-approved active Small molecule Quality 2/100

Aripezil® Tablet, marketed by Yuhan Corporation, holds a position in the pharmaceutical market with its key composition patent set to expire in 2028. The drug's primary strength lies in its current market presence, leveraging its established patient base and brand recognition. The primary risk is the potential increase in competition post-patent expiry, which could erode market share and revenue.

At a glance

Generic name	Aripezil® Tab.
Sponsor	Yuhan Corporation
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results